NEO · Healthcare · $472M
$18.36-2.03%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 39 Medical - Diagnostics & Research peers
Quarterly Revenue Growth
“NeoGenomics의 가장 큰 성장 엔진은 'NGS(차세대 유전자 분석)' 사업이에요.”
In the company's words · 2026 1분기 earnings call